WEREWOLF THERAPEUTICS, INC.

Analyst Reco. Werewolf Therapeutics, Inc.

Equities

HOWL

US95075A1079

Market Closed - Nasdaq Other stock markets 21:00:00 02/05/2024 BST			5-day change	1st Jan Change
6.08 ^USD	+1.00%		-2.09%	+57.51%

04-23	Werewolf Therapeutics, Inc. Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease at AAI Annual Meeting	CI
04-05	Werewolf Therapeutics, Inc. Presents Preclinical Results Demonstrating Anti-Tumor Effects of Pro-Inflammatory Cytokine Therapeutics	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JMP Securities Starts Werewolf Therapeutics With Market Outperform Rating, $12 Price Target	04-03	MT
Wedbush Starts Werewolf Therapeutics at Outperform With $9 Price Target	24/08/23	MT
EF Hutton Starts Werewolf Therapeutics at Buy With $8.30 Price Target	05/12/22	MT
History shows stocks can weather rate hike cycle	16/03/22	RE
SVB Leerink Adjusts Werewolf Therapeutics' Price Target to $28 from $29, Keeps Outperform Rating	19/11/21	MT
WEREWOLF THERAPEUTICS : BofA Securities Initiates Coverage on Werewolf Therapeutics With Buy Rating, $26 Price Target	10/09/21	MT
WEREWOLF THERAPEUTICS : Evercore ISI Group Initiates Werewolf Therapeutics at Outperform With $23 Price Target	25/05/21	MT
WEREWOLF THERAPEUTICS : SVB Leerink Initiates Coverage on Werewolf Therapeutics With Outperform Rating, $29 Price Target	25/05/21	MT
WEREWOLF THERAPEUTICS : HC Wainwright Starts Werewolf Therapeutics at Buy With $32 Price Target	25/05/21	MT
WEREWOLF THERAPEUTICS : Jefferies Starts Werewolf Therapeutics at Buy With $22 Price Target	25/05/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer